We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Single Vial Transport for Intestinal Parasites Launched

By LabMedica International staff writers
Posted on 17 Jun 2015
Print article
Image: Trichuris trichiura (whipworm) ova from a stool specimen (Photo courtesy of the US Centers for Disease Control and Prevention).
Image: Trichuris trichiura (whipworm) ova from a stool specimen (Photo courtesy of the US Centers for Disease Control and Prevention).
A one-vial, multipurpose, transport solution for the collection, transportation, preservation and examination of intestinal parasites in stool specimens has been launched.

Traditional ova and parasite examination procedures, as well as fecal antigen immunoassay tests, require different types of preservatives/transports to run a complete parasitological examination.

The new transport medium allows laboratorians to perform all of the testing from one vial, a significant improvement over multi-vial systems. Stool specimens preserved in Para-Pak SVT (Meridian Bioscience, Inc.; Cincinnati, OH, USA) can be used for direct examination, concentration, permanent stain and will not interfere with fecal immunoassays. The new Para-Pak SVT (Single Vial Transport) is also mercury, polyvinyl-alcohol (PVA) and formalin free, a more eco-friendly alternative for the laboratories when it comes to handling and disposal. As experts in parasitology and leaders in pre-analytic collection systems, including stool collection and transport systems, Meridian Bioscience continues to develop innovative products that meet the needs of today's healthcare providers.

Michael C. Shaughnessy, Executive Vice President and President Meridian Global Diagnostics, said, “Over 20,000,000 stool transport systems are used in the USA annually and the development of Para-Pak SVT provides a simplified solution for healthcare providers by offering a one patient–one transport vial approach that helps reduce potential errors associated with traditional multi-vial systems, and also offers improved work-flow options for laboratories. This is a single transport system that is cost effective and adds testing flexibility to the lab, allowing them to perform from ova and parasite (O&P) examination and fecal immunoassays from one vial.”

Related Links:

Meridian Bioscience, Inc. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.